JP2007510707A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007510707A5 JP2007510707A5 JP2006538974A JP2006538974A JP2007510707A5 JP 2007510707 A5 JP2007510707 A5 JP 2007510707A5 JP 2006538974 A JP2006538974 A JP 2006538974A JP 2006538974 A JP2006538974 A JP 2006538974A JP 2007510707 A5 JP2007510707 A5 JP 2007510707A5
- Authority
- JP
- Japan
- Prior art keywords
- chlorophenyl
- trifluoroethyl
- triaza
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51828003P | 2003-11-07 | 2003-11-07 | |
| PCT/IB2004/003522 WO2005044822A1 (en) | 2003-11-07 | 2004-10-25 | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007183117A Division JP2007302685A (ja) | 2003-11-07 | 2007-07-12 | 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007510707A JP2007510707A (ja) | 2007-04-26 |
| JP2007510707A5 true JP2007510707A5 (https=) | 2007-12-06 |
| JP4056549B2 JP4056549B2 (ja) | 2008-03-05 |
Family
ID=34572986
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538974A Expired - Fee Related JP4056549B2 (ja) | 2003-11-07 | 2004-10-25 | 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用 |
| JP2007183117A Withdrawn JP2007302685A (ja) | 2003-11-07 | 2007-07-12 | 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007183117A Withdrawn JP2007302685A (ja) | 2003-11-07 | 2007-07-12 | 二環式ピラゾリルおよびイミダゾリル化合物ならびにその使用 |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US7151097B2 (https=) |
| EP (1) | EP1682554A1 (https=) |
| JP (2) | JP4056549B2 (https=) |
| KR (1) | KR20060086396A (https=) |
| CN (1) | CN1886407A (https=) |
| AP (1) | AP2006003601A0 (https=) |
| AR (1) | AR046831A1 (https=) |
| AU (1) | AU2004286909A1 (https=) |
| BR (1) | BRPI0416299A (https=) |
| CA (1) | CA2544752A1 (https=) |
| CR (1) | CR8387A (https=) |
| DO (1) | DOP2004001024A (https=) |
| EA (1) | EA009742B1 (https=) |
| EC (1) | ECSP066549A (https=) |
| GT (1) | GT200400226A (https=) |
| HR (1) | HRP20060166A2 (https=) |
| IL (1) | IL175283A0 (https=) |
| IS (1) | IS8426A (https=) |
| MA (1) | MA28151A1 (https=) |
| MX (1) | MXPA06005023A (https=) |
| NL (1) | NL1027434C2 (https=) |
| NO (1) | NO20062618L (https=) |
| OA (1) | OA13280A (https=) |
| PA (1) | PA8616801A1 (https=) |
| PE (1) | PE20050576A1 (https=) |
| TN (1) | TNSN06129A1 (https=) |
| TW (2) | TWI280245B (https=) |
| WO (1) | WO2005044822A1 (https=) |
| ZA (1) | ZA200603594B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
| EP1603585A2 (en) * | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| US7151097B2 (en) * | 2003-11-07 | 2006-12-19 | Pfizer Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| ITMI20041032A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Compositi farmaceutici |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
| CN101027285A (zh) * | 2004-09-27 | 2007-08-29 | 辉瑞产品公司 | 制备双环吡唑基化合物的方法 |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| EP1874779A1 (en) * | 2005-04-20 | 2008-01-09 | Pfizer Products Inc. | Acylaminobicyclic heteromatic compounds as cannabinoid receptor ligands |
| EP1890767A2 (en) * | 2005-05-27 | 2008-02-27 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US7825151B2 (en) * | 2005-09-23 | 2010-11-02 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
| US8378096B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| EP1951678A1 (en) * | 2005-10-21 | 2008-08-06 | Mitsubishi Tanabe Pharma Corporation | Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| WO2007060525A2 (en) | 2005-11-28 | 2007-05-31 | Pfizer Products Inc. | Process for preparing bicyclic pyrazolyl and imidazolyl compounds |
| WO2007096763A2 (en) * | 2006-02-23 | 2007-08-30 | Pfizer Limited | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| WO2008048648A2 (en) * | 2006-10-17 | 2008-04-24 | Acadia Pharmaceuticals Inc. | Cb1-modulating compounds and their use |
| CN101583593A (zh) | 2006-11-13 | 2009-11-18 | 辉瑞产品公司 | 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途 |
| US20090062253A1 (en) * | 2007-08-31 | 2009-03-05 | Kalypsys, Inc. | Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| KR101280786B1 (ko) * | 2008-08-06 | 2013-07-05 | 화이자 리미티드 | 멜라노코르틴 4 작용제로서 다이아제핀 및 다이아조칸 화합물 |
| US9549006B2 (en) * | 2013-07-31 | 2017-01-17 | Cisco Technology, Inc. | Self-adaptive sample period for content sharing in communication sessions |
| ES2799582T3 (es) * | 2013-11-08 | 2020-12-18 | Incyte Holdings Corp | Proceso para la síntesis de un inhibidor de indoleamina 2,3-dioxigenasa |
| WO2020060761A2 (en) | 2018-09-04 | 2020-03-26 | Skodda Anja | Pet food formulation with cannabinoids |
| US11504416B2 (en) | 2018-09-04 | 2022-11-22 | Paw Power, Inc. | Formulation with cannabinoids |
| PH12022550233A1 (en) | 2019-08-09 | 2022-12-19 | Nihon Nohyaku Co Ltd | Oxazepinone derivative, insecticide for agricultural and horticultural use containing said derivative, and method for using same |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058869A2 (en) | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| CA2457922A1 (en) | 2001-08-31 | 2003-03-13 | University Of Connecticut | Novel pyrazole analogs acting on cannabinoid receptors |
| MXPA04002249A (es) | 2001-09-24 | 2004-06-29 | Bayer Pharmaceuticals Corp | Preparacion y uso de derivados de 1,5,6,7,-tetrahidro-pirrolo[3,2-c]piridina para el tratamiento de la obesidad. |
| GB0207249D0 (en) | 2002-03-27 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| US20040077650A1 (en) | 2002-10-18 | 2004-04-22 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US20040214856A1 (en) | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| WO2004098520A2 (en) | 2003-05-01 | 2004-11-18 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| MXPA05011922A (es) | 2003-05-07 | 2006-02-17 | Pfizer Prod Inc | Ligandos del receptor de cannabinoides y sus usos. |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| US20040259887A1 (en) | 2003-06-18 | 2004-12-23 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US20050026983A1 (en) | 2003-07-30 | 2005-02-03 | Pfizer Inc | Imidazole compounds and uses thereof |
| US7151097B2 (en) * | 2003-11-07 | 2006-12-19 | Pfizer Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| CN101027285A (zh) * | 2004-09-27 | 2007-08-29 | 辉瑞产品公司 | 制备双环吡唑基化合物的方法 |
-
2004
- 2004-10-22 US US10/971,599 patent/US7151097B2/en not_active Expired - Fee Related
- 2004-10-25 CA CA002544752A patent/CA2544752A1/en not_active Abandoned
- 2004-10-25 WO PCT/IB2004/003522 patent/WO2005044822A1/en not_active Ceased
- 2004-10-25 EP EP04769741A patent/EP1682554A1/en not_active Withdrawn
- 2004-10-25 KR KR1020067008880A patent/KR20060086396A/ko not_active Abandoned
- 2004-10-25 JP JP2006538974A patent/JP4056549B2/ja not_active Expired - Fee Related
- 2004-10-25 HR HR20060166A patent/HRP20060166A2/xx not_active Application Discontinuation
- 2004-10-25 EA EA200600647A patent/EA009742B1/ru not_active IP Right Cessation
- 2004-10-25 AP AP2006003601A patent/AP2006003601A0/xx unknown
- 2004-10-25 OA OA1200600145A patent/OA13280A/en unknown
- 2004-10-25 CN CNA2004800352698A patent/CN1886407A/zh active Pending
- 2004-10-25 BR BRPI0416299-4A patent/BRPI0416299A/pt not_active IP Right Cessation
- 2004-10-25 AU AU2004286909A patent/AU2004286909A1/en not_active Abandoned
- 2004-10-25 MX MXPA06005023A patent/MXPA06005023A/es not_active Application Discontinuation
- 2004-11-02 TW TW093133372A patent/TWI280245B/zh not_active IP Right Cessation
- 2004-11-02 TW TW095142275A patent/TW200716135A/zh unknown
- 2004-11-02 PA PA20048616801A patent/PA8616801A1/es unknown
- 2004-11-03 DO DO2004001024A patent/DOP2004001024A/es unknown
- 2004-11-04 PE PE2004001074A patent/PE20050576A1/es not_active Application Discontinuation
- 2004-11-04 GT GT200400226A patent/GT200400226A/es unknown
- 2004-11-05 AR ARP040104075A patent/AR046831A1/es not_active Application Discontinuation
- 2004-11-05 NL NL1027434A patent/NL1027434C2/nl not_active IP Right Cessation
-
2006
- 2006-04-21 IS IS8426A patent/IS8426A/is unknown
- 2006-04-27 IL IL175283A patent/IL175283A0/en unknown
- 2006-05-05 ZA ZA200603594A patent/ZA200603594B/en unknown
- 2006-05-05 TN TNP2006000129A patent/TNSN06129A1/fr unknown
- 2006-05-05 CR CR8387A patent/CR8387A/es not_active Application Discontinuation
- 2006-05-05 MA MA29005A patent/MA28151A1/fr unknown
- 2006-05-05 EC EC2006006549A patent/ECSP066549A/es unknown
- 2006-06-07 NO NO20062618A patent/NO20062618L/no not_active Application Discontinuation
- 2006-09-07 US US11/470,695 patent/US20070027133A1/en not_active Abandoned
-
2007
- 2007-07-12 JP JP2007183117A patent/JP2007302685A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007510707A5 (https=) | ||
| EP1562949A4 (en) | METHOD FOR PRODUCING PYRROLOTRIAZIN COMPOUNDS SUITABLE AS KINASEINHIBITORS | |
| NO20081941L (no) | Pyrazol [1,5-alfa]pyrimidinylderivater nyttige som kortikotropin-frigivende faktor (CRF) reseptorantagonister | |
| KR880012558A (ko) | 진통활성을 갖는 아릴헤테로아릴 카르비놀 유도체와 그의 제조방법 | |
| CY1108378T1 (el) | 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu | |
| JP2001516732A5 (https=) | ||
| PE20081377A1 (es) | Compuestos de tiazol pirazolopirimidina | |
| ATE303366T1 (de) | 4-amino-5-cyano-2-anilino-pyrimidin-derivate zur verwendung als inhibitoren von zellzyklus-kinasen | |
| JP2005533804A5 (https=) | ||
| JP2006517220A5 (https=) | ||
| ATE447942T1 (de) | Verfahren zur herstellung einer gegen missbrauch gesicherten darreichungsform | |
| BRPI0413233A (pt) | novos compostos | |
| JP2001516757A5 (https=) | ||
| ATE395338T1 (de) | Pyrazolderivate, zusammensetzungen, die solche verbindungen enthalten, und anwendungsverfahren | |
| AU2003250753A1 (en) | Method for producing organic compounds containing poly-dopo, and the use of the same | |
| NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| MX2024003925A (es) | Terapia de combinación utilizando pirimidin-4(3h)-onas sustituidas y sotorasib | |
| RU2006144710A (ru) | Новые производные циклопента [b] бензофурана и их применение | |
| Fedotov et al. | Synthesis and properties of 6-(2, 6-dichlorophenyl)-3-(3-methyl-1H-pyrazol-5-yl)-6, 7-dihydro-5H-[1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine-7-carboxylic acid and its salts | |
| DE602004026333D1 (de) | NEUE KRISTALLINE FORMEN VON ä2-Ä1-(3,5-BISTRIFLUORMETHYLBENZYL)-5-PYRIDIN-4-YL-1H-Ä1,2,3ÜÜTRIAZOL-4-YLÜ-PYRIDIN-3-YLü-(2-CHLORPHENYL)METHANON | |
| JP2004508309A5 (https=) | ||
| JP2003513075A5 (https=) | ||
| ATE353331T1 (de) | Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin | |
| Krause et al. | Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H3-receptor agonist | |
| RU98119887A (ru) | Новые диарилметилиденфурановые производные, способы их получения и их использование в терапии |